The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 4,601–4,700 of 31,469
Duca, L. M., Maahs, D. M., Schauer, I. E., Bergman, B. C., Nadeau, K. J., Bjornstad, P., Rewers, M., & Snell‐Bergeon, J. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3272 · Cited by 76
Hagman, D. K., Larson, I. A., Kuzma, J. N., Cromer, G., Makar, K. W., Rubinow, K. B., Foster‐Schubert, K. E., Yserloo, B. V., Billing, P. S., Landerholm, R. W., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.030 · Cited by 76
Alferink, L. J. M., Fittipaldi, J., Jong, J. C. K., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.013 · Cited by 74
Arsenic exposure induces glucose intolerance and alters global energy metabolism
Kirkley, A. G., Carmean, C. M., Ruíz, D., Ye, H., Regnier, S. M., Poudel, A., Hara, M., Kamau, W., Johnson, D. N., Roberts, A. A., et al. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00522.2016 · Cited by 74
Kahleová, H., Hlozkova, A., Fleeman, R. M., Fletcher, K., Holubkov, R., & Barnard, N. D. (2019) · Nutrients · doi:10.3390/nu11030615 · Cited by 78
Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
Takei, R., Inoue, T., Sonoda, N., Kohjima, M., Okamoto, M., Sakamoto, R., Inoguchi, T., & Ogawa, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223302 · Cited by 75
Hernández-Baixauli, J., Quesada‐Vázquez, S., Mariné-Casadó, R., Cardoso, K. G., Caimari, A., Bas-Prior, J. M. D., Escoté, X., & Baselga‐Escudero, L. (2020) · Nutrients · doi:10.3390/nu12030806 · Cited by 74
Hernández‐Conde, M., Llop, E., Gómez-Pimpollo, L., Fernández‐Carrillo, C., Luis, R., den Brule, E. V., Perelló, C., López-Gómez, M., Abad, J., Porras, J. L. M., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001301 · Cited by 74
Human Gut Antibiotic Resistome and Progression of Diabetes
Shuai, M., Zhang, G., Zeng, F., Fu, Y., Liang, X., Yuan, L., Xu, F., Gou, W., Miao, Z., Jiang, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104965 · Cited by 74
Lee, H., An, J., Kim, J., Choi, D., Song, Y., Lee, C., Kong, H., Kim, S. B., & Kim, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.858192 · Cited by 78
Adipokines in Patients with Cancer Anorexia and Cachexia
Smiechowska, J., Utech, A. E., Taffet, G. E., Hayes, T. G., Marcelli, M., & Garcia, J. M. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181cf91ca · Cited by 74
Fraulob, J. C., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2012) · Clinical Science · doi:10.1042/cs20110373 · Cited by 76
Wang, Z. Q., Zhang, X. H., Yu, Y., Poulev, A., Ribnicky, D., Floyd, Z. E., & Cefalu, W. T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.09.004 · Cited by 75
Common variants of FTO and the risk of obesity and type 2 diabetes in Indians
Chauhan, G., Tabassum, R., Mahajan, A., Dwivedi, O. P., Mahendran, Y., Kaur, I., Nigam, S., Dubey, H., Varma, B., Madhu, S. V., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.87 · Cited by 77
Grassi, G. M., Seravalle, G., Brambilla, G., Trabattoni, D., Cuspidi, C., Corso, R., Pieruzzi, F., Genovesi, S., Stella, A., Facchetti, R., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04823 · Cited by 77
Physical activity, cardiorespiratory fitness and insulin resistance: a short update
Gill, J. M. R. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328012b8bd · Cited by 72
Insulin resistance and acute coronary syndrome
Caccamo, G., Bonura, F., Bonura, F., Vitale, G., Novo, G., Evola, S., Evola, G., Grisanti, M. R., & Novo, S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.03.033 · Cited by 74
Kuo, C.-K., Lin, L., Yu, Y., Wu, K.-H., & Kuo, H. (2009) · BMC Geriatrics · doi:10.1186/1471-2318-9-49 · Cited by 74
Yano, Y., Hoshide, S., Ishikawa, J., Hashimoto, T., Eguchi, K., Shimada, K., & Kario, K. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07321.x · Cited by 75
A common polymorphism of uncoupling protein 2 gene is associated with hypertension
Ji, Q., Ikegami, H., Fujisawa, T., Kawabata, Y., Ono, M., Nishino, M., Ohishi, M., Katsuya, T., Rakugi, H., & Ogihara, T. (2003) · Journal of Hypertension · doi:10.1097/00004872-200401000-00018 · Cited by 74
Choi, J. S., Jung, M. H., Park, H. S., & Song, J. (2004) · Nutrition · doi:10.1016/j.nut.2004.08.009 · Cited by 74
Electrically Induced Resistance Training in Individuals With Motor Complete Spinal Cord Injury
RYAN, T. E., Brizendine, J. T., Backus, D. A., & McCully, K. K. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.06.016 · Cited by 76
Improved cognitive-cerebral function in older adults with chromium supplementation
Krikorian, R., Eliassen, J. C., Boespflug, E. L., Nash, T. A., & Shidler, M. D. (2010) · Nutritional Neuroscience · doi:10.1179/147683010x12611460764084 · Cited by 74
Retinol to Retinol-Binding Protein (RBP) Is Low in Obese Adults due to Elevated apo -RBP
Mills, J. P., Furr, H. C., & Tanumihardjo, S. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0803-rm-94 · Cited by 73
Prior, S. J., Joseph, L., Brandauer, J., Katzel, L. I., Hagberg, J. M., & Ryan, A. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2113 · Cited by 74
Jung, C., Rhee, E., Choi, J., Bae, J.-C., Yoo, S.-H., Kim, W., Park, C., Mok, J., Kim, C., Lee, W., et al. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.4.237 · Cited by 74
Yang, F., Wang, G., Wang, Z., Sun, M., Cao, M., Zhu, Z., Fu, Q., Mao, J., Shi, Y., & Yang, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104365 · Cited by 73
Sanghera, D. K., Demirci, F. Y., Been, L. F., Ortega, L., Ralhan, S. K., Wander, G. S., Mehra, N. K., Singh, J., Aston, C. E., Mulvihill, J. J., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.043 · Cited by 76
Celis-Morales, C. A., Pérez‐Bravo, F., Ibañes, L., Sanzana, R., Hormazabal, E., Natalia Ulloa, M., Calvo, C., Bailey, M. E. S., & Gill, J. M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024690 · Cited by 74
Cicero, A. F. G., Derosa, G., Bove, M., Imola, F., Borghi, C., & Gaddi, A. V. (2009) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-009-0056-1 · Cited by 74
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis†
Cammà, C., Petta, S., Marco, V. D., Bronte, F., Ciminnisi, S., Licata, G., Peralta, S., Simone, F., Marchesini, G., & Craxı̀, A. (2008) · Hepatology · doi:10.1002/hep.22655 · Cited by 73
Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
Wang, R., Ross, C. A., Cai, H., Cong, W., Daimon, C. M., Carlson, O. D., Egan, J. M., Siddiqui, S., Maudsley, S. R., & Martin, B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00231 · Cited by 75
Alfadda, A. A., Sallam, R. M., Chishti, M. A., Moustafa, A. S., Fatma, S., AlOmaim, W. S., Al-Naami, M. Y., Bassas, A. F., Chrousos, G. P., & Jo, H. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0012-7 · Cited by 74
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease
Sönmez, A., Nikolić, D., Doğru, T., Erçin, C. N., Genç, H., Cesur, M., Tapan, S., Karslıoğlu, Y., Montalto, G., Banach, M., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.03.010 · Cited by 74
Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada
Liu, J., Hanley, A. J., Young, T. K., Harris, S. B., & Zinman, B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803179 · Cited by 79
Iron supplementation and gestational diabetes in midpregnancy
Bo, S., Menato, G., Villois, P., Gambino, R., Cassader, M., Cotrino, I., & Cavallo‐Perin, P. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.04.049 · Cited by 79
SHBG levels correlate with insulin resistance in postmenopausal women
Akın, F., Baştemir, M., Alkış, E., & Kaptanoğlu, B. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.09.023 · Cited by 74
Barbonetti, A., Caterina Vassallo, M. R., Cotugno, M., Felzani, G., Francavilla, S., & Francavilla, F. (2016) · The Journal of Spinal Cord Medicine · doi:10.1179/2045772314y.0000000288 · Cited by 75
Wu, Y., Zhang, J., Wen, Y., Wang, H., Zhang, M., & Cianflone, K. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.031 · Cited by 74
Insulin Resistance Is Associated With Cognition Among HIV-1-Infected Patients
Valcour, V., Sacktor, N. C., Paul, R. H., Watters, M. R., Selnes, O. A., Shiramizu, B. T., Williams, A. E., & Shikuma, C. M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000243119.67529.f5 · Cited by 74
Kawamori, R. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.296 · Cited by 74
Adiponectin and Resistin Response in the Onset of Obesity in Male and Female Rats
Ribot, J., Rodríguez, A. M., Rodríguez, E., & Palou, A. (2008) · Obesity · doi:10.1038/oby.2008.113 · Cited by 74
Lee, C.-C., Hsu, W.-H., Shen, S.-R., Cheng, Y.-H., & Wu, S. (2012) · Experimental Diabetes Research · doi:10.1155/2012/375673 · Cited by 74
Stenkamp-Strahm, C. M., Kappmeyer, A. J., Schmalz, J. T., Gericke, M. T., & Balemba, O. B. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1681-z · Cited by 75
Effect of Testosterone on Insulin Sensitivity in Men with Idiopathic Hypogonadotropic Hypogonadism
Naharcı, M. İ., Pinar, M., Bolu, E., & Olgun, A. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.629 · Cited by 74
Svegliati‐Baroni, G., Bugianesi, E., Bouserhal, T., Marini, F., Ridolfi, F., Tarsetti, F., Ancarani, F., Petrelli, E., Peruzzi, E., Cascio, M. L., et al. (2007) · Gut · doi:10.1136/gut.2006.107946 · Cited by 73
Adherence to the Mediterranean diet and serum uric acid: the ATTICA study
Kontogianni, M. D., Chrysohoou, C. A., Panagiotakos, D., Tsetsekou, E., Zeimbekis, A., Pitsavos, C. E., & Stefanadis, C. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.679964 · Cited by 74
Corella, D., Qi, L., Tai, E. S., Deurenberg‐Yap, M., Tan, C. E., Chew, S. K., & Ordovás, J. M. (2006) · Diabetes Care · doi:10.2337/dc06-0045 · Cited by 74
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Takayama, S., Abe, M., Katoh, T., & Ohtsuka, N. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-79 · Cited by 73
Effects of Isoflavone Dietary Supplementation on Cardiovascular Risk Factors in Type 2 Diabetes
González, S., Jayagopal, V., Kilpatrick, E. S., Chapman, T., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1814 · Cited by 73
Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease
Trovato, G. M., Martines, G. F., Garozzo, A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02127.x · Cited by 74
Mouquet, F., Cuilleret, F., Susen, S., Sautière, K., Marboeuf, P., Ennezat, P. V., McFadden, E. P., Pigny, P., Richard, F., Hennache, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn569 · Cited by 74
Heshmat, R., Tabatabaei‐Malazy, O., Abbaszadeh-Ahranjani, S., Shahbazi, S., Khooshehchin, G., Bandarian, F., & Larijani, B. A. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-10 · Cited by 74
Trirogoff, M. L., Shintani, A., Himmelfarb, J., & Ikizler, T. A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1642 · Cited by 74
Steroid Hormone Profiles in Prepubertal Obese Children Before and After Weight Loss
Reinehr, T., Kulle, A. E., Wolters, B., Lass, N., Welzel, M., Riepe, F. G., & Holterhus, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1173 · Cited by 75
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 76
RetractedVural, P., Değirmencioğlu, S., Saral, N. Y., & Akgül, C. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.010 · Cited by 74
Household Wealth and the Metabolic Syndrome in the Whitehall II Study
Perel, P., Langenberg, C., Ferrie, J. E., Moser, K. A., Brunner, E. J., & Marmot, M. G. (2006) · Diabetes Care · doi:10.2337/dc06-0022 · Cited by 74
Hodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Borén, J., Marinou, K., Fisher, C., Mostad, I. L., STRATTON, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 73
Billeter, A. T., Senft, J. D., Gotthardt, D. N., Knefeli, P., Nickel, F., Schulte, T., Fischer, L., Nawroth, P. P., Büchler, M. W., & Müller-Stich, B. P. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2006-y · Cited by 75
Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans
Lalia, A. Z., Dasari, S., Johnson, M. L., Robinson, M. M., Konopka, A. R., Distelmaier, K., Port, J. D., Glavin, M., Esponda, R. R., Nair, K. S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2892 · Cited by 78
Polyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism
Coelho, O. G. L., da Silva, B. P., Rocha, D. M. U. P., Lopes, L. L., & Alfenas, R. D. C. G. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1130016 · Cited by 73
Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela
Bermúdez, V., Salazar, J. J., Martínez, M. S., Chávez-Castillo, M., Olivar, L. C., Calvo, M. C. C., Palmar, J., Bautista, J., Ramos, E., Cabrera, M., et al. (2016) · Advances in Preventive Medicine · doi:10.1155/2016/9405105 · Cited by 75
Metabolomics Profiling for Obstructive Sleep Apnea and Simple Snorers
Xu, H., Zheng, X., Qian, Y., Guan, J., Yi, H., Zou, J., Wang, Y., Meng, L., Zhao, A., Yin, S., et al. (2016) · Scientific Reports · doi:10.1038/srep30958 · Cited by 73
Chen, D. C., Du, X., Yin, G. Z., Yang, K., Nie, Y., Wang, N., Li, Y., Xiu, M., He, S. C., Yang, F. D., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716001902 · Cited by 74
Pala, D., Barbosa, P. O., Silva, C. T., de Souza, M. O., Freitas, F. R., Volp, A. C. P., Maranhão, R. C., & de Freitas, R. N. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.02.001 · Cited by 74
Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study
Brahimaj, A., Ligthart, S., Ghanbari, M., Ikram, M. A., Albert Hofman, D., Franco, O. H., Kavousi, M., & Dehghan, A. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0236-0 · Cited by 72
Methods for quantifying adipose tissue insulin resistance in overweight/obese humans
ter Horst, K. W., van Galen, K. A., Gilijamse, P. W., Hartstra, A. V., de Groot, P. F., van der Valk, F. M., Ackermans, M. T., Nieuwdorp, M., Romijn, J. A., & Serlie, M. J. M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.110 · Cited by 78
Lee, Y., Ha, C., Kim, S.-A., Thoudam, T., Yoon, Y.-R., Kim, D. J., Kim, H. C., Moon, H., Park, S., Lee, I., et al. (2017) · Diabetes · doi:10.2337/db17-0188 · Cited by 74
Tada, T., Kumada, T., Toyoda, H., Sone, Y., Takeshima, K., Ogawa, S., Goto, T., Wakahata, A., Nakashima, M., Nakamuta, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14554 · Cited by 75
Lind, M. V., Lauritzen, L., Kristensen, M., Ross, A. B., & Eriksen, J. N. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy234 · Cited by 74
Ruan, Q., Huang, Y., Yang, L., Ruan, J., Gu, W., Zhang, X., Zhang, Y., Zhang, W., & Yu, Z. (2019) · Peptides · doi:10.1016/j.peptides.2019.01.004 · Cited by 79
Vilsbøll, T., Krarup, T., Madsbad, S., & Holst, J. J. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00424.x · Cited by 72
Derosa, G., Cicero, A. F. G., Gaddi, A. V., et al. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.10.007 · Cited by 74
Tan, M. H., Johns, D., Strand, J., Halse, J., Madsbad, S., Eriksson, J. W., Clausen, J., Konkoy, C. S., Herz, M., & for the GLAC Study Group (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01258.x · Cited by 73
Henkel, E., Menschikowski, M., Koehler, C., Leonhardt, W., & Hanefeld, M. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.024 · Cited by 74
Lawlor, D. A., Ebrahim, S. B. J., Timpson, N. J., & Smith, G. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01537.x · Cited by 74
Choi, K. M., Lee, J., Lee, K. W., Seo, J. A., Oh, J.-H., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.10.007 · Cited by 74
Kim, J., Lee, Y., Kye, S., Chung, Y., & Lee, O. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12154 · Cited by 71
A critical review of endpoints for non-cirrhotic NASH therapeutic trials
Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74
Tura, A., Sbrignadello, S., Succurro, E., Groop, L., Sesti, G., & Pacini, G. (2010) · Diabetologia · doi:10.1007/s00125-009-1547-9 · Cited by 71
Kenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
“Insulin resistance was calculated using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) [35], according to the formula: HOMA-IR = (insulin (mU / L) × glucose (mmol / L)) / 22.5.”
InfluentialBailey, C. J., Bagdonas, A., Rubes, J., McMorn, S. O., Donaldson, J., Biswas, N., & Stewart, M. W. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.10.012 · Cited by 73
CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects
Holdstock, C., Lind, L., Engstrom, B. E., Ohrvall, M., Sundbom, M., Larsson, A., & Karlsson, F. A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803000 · Cited by 73
Haufe, S., Utz, W., Engeli, S., Kast, P., Böhnke, J., Pofahl, M., Traber, J., Haas, V., Hermsdorf, M., Mähler, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.178616 · Cited by 73
Warolin, J., Coenen, K. R., Kantor, J., Whitaker, L., Wang, L., Acra, S. A., Roberts, L. J., & Buchowski, M. S. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00135.x · Cited by 76
Lazzeri, C., Sori, A., Chiostri, M., Gensini, G. F., & Valente, S. (2009) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32832a235c · Cited by 73
Metabolic Risk Varies According to Waist Circumference Measurement Site in Overweight Boys and Girls
Johnson, S. T., Kuk, J. L., Mackenzie, K. A., Huang, T. T. ‐., Rosychuk, R. J., & Ball, G. D. C. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.08.010 · Cited by 73
Macaluso, F. S., Maida, M. F., Cammà, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.045 · Cited by 73
Dirinck, E. L., Dirtu, A. C., Malarvannan, G., Covaci, A., Gaal, L. F. V., & Jorens, P. G. (2014) · Diabetes Care · doi:10.2337/dc13-2329 · Cited by 74
Serfaty, L., Forns, X., Goeser, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300749 · Cited by 73
Skrede, T., Stavnsbo, M., Aadland, E., Aadland, K. N., Anderssen, S. A., Resaland, G. K., & Ekelund, U. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.150540 · Cited by 78
Burris, J., Shikany, J. M., Rietkerk, W., & Woolf, K. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.02.009 · Cited by 75
Chu, S.-Y., Jung, J., Park, M.-J., & Kim, S.-H. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.1.41 · Cited by 78
Yan, Y., Li, S., Liu, Y., Bazzano, L., He, J., Mi, J., & Chen, W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0913-2 · Cited by 77
Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
Finucane, F. M., & Davenport, C. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00184 · Cited by 74
Wu, J., Xu, Y., Su, J., Zhu, B., Wang, S., Liu, K., Wang, H., Shi, S., Zhang, Q., Qin, L., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116780 · Cited by 74
Yang, X., Wang, G., Jing, J., Wang, A., Zhang, X., Jia, Q., Meng, X., Zhao, X., Liu, L., Li, H., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02588-3 · Cited by 75
Eldosoky, M. A. E. R., Hammad, R., Elmadbouly, A. A. E., Aglan, R. B., AbdelHamid, S. G., Alboraie, M. A. A., Hassan, D. A., Shaheen, M. A. A., Rushdi, A., Ahmed, R. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043157 · Cited by 73
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., & Archimandritis, A. J. (2007) · Journal of Hepatology · doi:10.1016/s0168-8278(07)62365-4 · Cited by 73
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
